Document:

Exhibit 10.1

 

SUBSCRIPTION AGREEMENT

 

Stable Road Acquisition Corp.

1345 Abbot Kinney Blvd

Venice, California 90291

 

Ladies and Gentlemen:

 

This Subscription Agreement
(this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto,
by and between Stable Road Acquisition Corp., a Delaware corporation (“SRAC”), and the undersigned subscriber
(the “Investor”), in connection with the Agreement and Plan of Merger, dated as of the date hereof (as may be
amended, supplemented or otherwise modified from time to time, the “Transaction Agreement”), by and among SRAC,
Momentus Inc., a Delaware corporation (the “Company”), Project Marvel First Merger Sub, Inc., a Delaware corporation
and a direct, wholly-owned subsidiary of SRAC (“First Merger Sub”) and Project Marvel Second Merger Sub, LLC,
a Delaware limited liability company and a direct, wholly-owned subsidiary of SRAC (“Second Merger Sub”), pursuant
to which, among other things, First Merger Sub will merge with and into the Company, with the Company as the surviving corporation
of such merger (the “Surviving Corporation”), and immediately thereafter and as part of the same overall transaction,
the Surviving Corporation will merge with and into Second Merger Sub, with Second Merger Sub surviving such merger as a wholly-owned
subsidiary of SRAC, on the terms and subject to the conditions therein (the transactions contemplated by the Transaction Agreement,
including the merger, the “Transaction”).  In connection with the
Transaction, SRAC is seeking commitments from interested investors to purchase, substantially concurrently with the closing of
the Transaction, shares of SRAC’s Class A Common Stock, par value $0.0001 per share (the “Shares”), in
a private placement for a purchase price of $10.00 per share. The aggregate purchase price to be paid by the Investor for the subscribed
Shares (as set forth on the signature page hereto) is referred to herein as the “Subscription Amount.” 

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions,
set forth herein, and intending to be legally bound hereby, each of the Investor and SRAC acknowledges and agrees as follows:

 

1. Subscription.
The Investor hereby irrevocably subscribes for and agrees to purchase from SRAC the number of Shares set forth on the signature
page of this Subscription Agreement on the terms and subject to the conditions provided for herein. The Investor acknowledges
and agrees that SRAC reserves the right to accept or reject the Investor’s subscription for the Shares for any reason or
for no reason, in whole or in part, at any time prior to its acceptance, and the same shall be deemed to be accepted by SRAC only
when this Subscription Agreement is signed by a duly authorized person by or on behalf of SRAC.

 

2. Closing.
The closing of the sale of the Shares contemplated hereby (the “Closing”)
shall occur on the date of and substantially concurrently with and conditioned upon the closing of the Transaction (such
date, the “Closing Date”). At least five (5) business days prior to the anticipated Closing Date, SRAC
shall deliver a written notice (the “Closing Notice”) to the Investor, specifying (a) the anticipated
Closing Date and (b) wire instructions for the account(s) into which the Investor shall fund the Subscription Amount. No
later than two (2) business days prior to the Closing Date, the Investor shall deliver (i) the Subscription Amount by wire
transfer of United States dollars in immediately available funds to the account(s) specified by SRAC in the Closing Notice
and (ii) any other information that is reasonably requested in the Closing Notice in order for SRAC to issue the
Investor’s Shares, including, without limitation, the legal name of the person in whose name such Shares are to be
issued and a duly executed Internal Revenue Service Form W-9 or W-8, as applicable. On the Closing Date, SRAC shall deliver
to the Investor the number of Shares set forth on the signature page to this Subscription Agreement in book entry form, free
and clear of any liens or other restrictions whatsoever (other than those set forth in this Subscription Agreement, arising
under any written agreement to which the Investor is a party or arising under state or federal securities laws), in the name
of the Investor (or its nominee in accordance with its delivery instructions) by causing such Shares to be registered on
SRAC’s share register; provided, however, that SRAC’s obligation to issue the Shares to the Investor is
contingent upon SRAC having received the Subscription Amount in full accordance with this Section 2. In the event the
closing of the Transaction does not occur within five (5) business days of the Closing Date specified in the Closing Notice,
unless otherwise instructed by the Investor, SRAC shall promptly (but not later than one (1) business day thereafter) return
the Subscription Amount to the Investor by wire transfer of U.S. dollars in immediately available funds to the account
specified by the Investor, and any book entries shall be deemed cancelled. For purposes of this Subscription Agreement,
“business day” shall mean a day, other than a Saturday or Sunday, on which commercial banks in New York, New York
and Los Angeles, California are open for the general transaction of business.

 

     

    Confidential

    

 

3. Closing Conditions.

 

a. The
obligations of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is
subject to the following conditions:

 

(i) no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation which is then in effect and has the effect of making the consummation of the transactions contemplated hereby illegal
or otherwise restraining or prohibiting consummation of the transactions contemplated hereby; and

 

(ii) all
conditions precedent to the closing of the Transaction under the Transaction Agreement shall have been satisfied or waived (as
determined by the parties to the Transaction Agreement and other than those conditions under the Transaction Agreement which, by
their nature, are to be fulfilled at the closing of the Transaction, including to the extent that any such condition is dependent
upon the consummation of the purchase and sale of the Shares pursuant to this Subscription Agreement, but subject to the satisfaction
or waiver of such conditions at the closing of the Transaction) and the closing of the Transaction shall occur, in accordance with
the terms of the Transaction Agreement, on the Closing Date, substantially concurrently with the Closing.

 

b. The
obligation of SRAC to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement shall be subject to
the conditions that (i) all representations and warranties of the Investor contained in this Subscription Agreement be true and
correct in all material respects when made, and be true and correct in all material respects on and as of the Closing Date (unless
they specifically speak as of an earlier date in which case they shall be true and correct in all material respects as of such
date), and the Investor hereby acknowledges that the consummation of the Closing shall constitute a reaffirmation by the Investor
of each of the representations and warranties of the Investor contained in this Subscription Agreement as of the Closing Date;
and (ii) all obligations, covenants and agreements of the Investor required to be performed by it at or prior to the Closing Date
shall have been performed in all material respects.

 

c. The
obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall be subject to
the condition that (i) all representations and warranties of SRAC contained in this Subscription Agreement shall be true and correct
in all material respects when made (other than representations and warranties that are qualified as to materiality or Material
Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) and be true and correct
in all material respects at and as of the Closing Date (unless they specifically speak as of an earlier date in which case they
shall be true and correct in all material respects as of such date) (other than representations and warranties that are qualified
as to materiality or Material Adverse Effect, which representations and warranties shall be true in all respects) and SRAC hereby
acknowledges that the consummation of the Closing shall constitute a reaffirmation by SRAC of each of the representations and warranties
of SRAC contained in this Subscription Agreement as of the Closing Date; (ii) all obligations, covenants and agreements of SRAC
required to be performed by it at or prior to the Closing Date shall have been performed in all material respects; (iii) the transactions
contemplated by this Subscription Agreement and the other subscription agreements related to the private placement of the Shares
for the issuance of at least an aggregate of 10,000,000 Shares generating proceeds to SRAC of at least $100,000,000 shall close
substantially concurrently with the closing of the Transaction; and (iv) no amendment or modification of the Transaction Agreement
shall have occurred that materially and adversely affects the Investor’s economic benefits under this Subscription Agreement.

 

4. Further Assurances.
At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions as the
parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription
Agreement.

 

    2

    Confidential

    

 

5. SRAC Representations
and Warranties. SRAC represents and warrants to the Investor that:

 

a. SRAC
is duly incorporated, validly existing and in good standing under the laws of the State of Delaware. SRAC has all power (corporate
or otherwise) and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter
into, deliver and perform its obligations under this Subscription Agreement.

 

b. As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor in exchange for the Subscription
Amount in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable
and will not have been issued in violation of any preemptive or similar rights created under SRAC’s certificate of incorporation
(as amended as of the Closing Date) or under the General Corporation Law of the State of Delaware.

 

c. This
Subscription Agreement and the Transaction Agreement (collectively, the “Transaction Documents”) have been duly
authorized, executed and delivered by SRAC and, assuming that the Transaction Documents constitute the valid and binding agreement
of the other parties thereto, the Transaction Documents are enforceable against SRAC in accordance with their respective terms,
except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law
or equity.

 

d. The
execution and delivery of, and the performance of the transactions contemplated by this Subscription Agreement and the other Transaction
Documents, including the issuance and sale of the Shares and the compliance by SRAC with all of the provisions of this Subscription
Agreement and the consummation of the transactions contemplated herein, will not (i) conflict with or result in a breach or violation
of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge
or encumbrance upon any of the property or assets of SRAC or any of its subsidiaries pursuant to the terms of any indenture, mortgage,
deed of trust, loan agreement, lease, license or other agreement or instrument to which SRAC or any of its subsidiaries is a party
or by which SRAC or any of its subsidiaries is bound or to which any of the property or assets of SRAC is subject that would reasonably
be expected to have a material adverse effect on the business, financial condition or results of operations of SRAC and its subsidiaries,
taken as a whole (a “Material Adverse Effect”) or materially affect
the validity of the Shares or the legal authority of SRAC to comply in all material respects with the terms of this Subscription
Agreement; (ii) result in any violation of the provisions of the organizational documents of SRAC; or (iii) result in any violation
of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having
jurisdiction over SRAC or any of its properties that would reasonably be expected to have a Material Adverse Effect or materially
affect the validity of the Shares or the legal authority of SRAC to comply in all material respects with this Subscription Agreement.

 

e. As
of their respective dates, all reports (the “SEC Reports”) required to be filed by SRAC with the U.S. Securities
and Exchange Commission (the “SEC”) complied in all material respects with the applicable requirements of the
Securities Act of 1933, as amended (the “Securities Act”), and/or the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

f. Except for such
matters as have not had and would not be reasonably likely to have, individually or in the aggregate, a Material Adverse
Effect, as of the date hereof, there is no (i) action, suit, claim or other proceeding, in each case by or before any
governmental authority pending, or, to the knowledge of SRAC, threatened against SRAC or (ii) judgment, decree, injunction,
ruling or order of any governmental entity or arbitrator outstanding against SRAC.

 

    3

    Confidential

    

 

g. As
of the date of this Subscription Agreement, the authorized capital stock of SRAC consists of (i) 1,000,000 preferred shares
of SRAC, par value $0.0001 per share (“Preferred Stock”), of which no shares of Preferred Stock are issued and
outstanding; (ii) 100,000,000 Shares, of which 17,795,000 Shares are issued and outstanding; (iii) 10,000,000 shares of Class B Common
Stock of SRAC, par value $0.0001 per share (“Class B Common Stock” and, together with the Preferred Stock and
the Shares, the “Total SRAC Shares”), of which 4,312,500 shares of Class B Common Stock are issued and outstanding;
(iv) 272,500 warrants to purchase one Share (the “Private Placement Warrants”), all of which are outstanding;
and (v) 8,625,000 warrants to purchase one Share (the “Public Warrants,” collectively with the Private Placement
Warrants, the “Warrants”), all of which are outstanding.  All outstanding Shares, Class B Common Stock,
Private Placement Warrants and Public Warrants have been duly authorized, validly issued, fully paid and are not subject to preemptive
rights. Except as set forth above and pursuant to the other subscription agreements, the
Transaction Agreement and the other agreements and arrangements referred to therein, as of the date hereof, there are no outstanding
options, warrants or other rights to subscribe for, purchase or acquire from SRAC any Shares, Class B Common Stock or other equity
interests in SRAC, or securities convertible into or exchangeable or exercisable for such equity interests. As of the date hereof,
SRAC has no subsidiaries, other than First Merger Sub and Second Merger Sub and does not own, directly or indirectly, interests
or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no shareholder agreements,
voting trusts or other agreements or understandings to which SRAC is a party or by which it is bound relating to the voting of
any securities of SRAC, other than (1) as set forth in the SEC Reports and (2) as contemplated by the Transaction Agreement.

 

h. As
of the date hereof, the issued and outstanding Shares are registered pursuant to Section 12(b) of the Exchange Act, and are
listed for trading on The Nasdaq Stock Market (“Nasdaq”) under the symbol “SRAC.” There is no suit,
action, proceeding or investigation pending or, to the knowledge of SRAC, threatened against SRAC by Nasdaq or the SEC with respect
to any intention by such entity to deregister such shares or prohibit or terminate the listing of the Shares on Nasdaq. SRAC has
taken no action that is designed to terminate the registration of such shares under the Exchange Act.

 

6. Investor Representations
and Warranties. The Investor represents and warrants to SRAC that:

 

a. The
Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional
“accredited investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the applicable
requirements set forth on Schedule A, (ii) is acquiring the Shares only for the Investor’s own account and not for
the account of others, or if the Investor is subscribing for the Shares as a fiduciary or agent for one or more investor accounts,
the Investor has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements,
representations and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Shares with
a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide
the requested information set forth on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring
the Shares.

 

b. The Investor
acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the
meaning of the Securities Act and that the Shares have not been registered under the Securities Act. The Investor
acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged (other than in connection with
ordinary course prime brokerage relationships) or otherwise disposed of by the Investor absent an effective registration
statement under the Securities Act except (i) to SRAC or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers
and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant
to another applicable exemption from the registration requirements of the Securities Act (including, without limitation, a
private resale pursuant to so-called Rule 4(1 1⁄2)), and, in each of clauses (i) and (iii) in accordance with any
applicable securities laws of the states and other jurisdictions of the United States, and that any certificates representing
the Shares shall contain a restrictive legend to such effect. The Investor acknowledges and agrees that the Shares will be
subject to transfer restrictions and, as a result of these transfer restrictions, the Investor may not be able to readily
offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk of an
investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares will not be
eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until
at least one year from the Closing Date. The Investor acknowledges and agrees that the Investor has been advised to consult
with its legal counsel and tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of
any of the Shares.

 

c. The
Investor acknowledges and agrees that the Investor is purchasing the Shares from SRAC. The Investor further acknowledges that there
have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of SRAC, the Company, any
of their respective affiliates or any control persons, direct or indirect equityholders, officers, managers, directors, employees,
consultants, partners, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication,
other than those representations, warranties, covenants and agreements of SRAC expressly set forth in Section 5 of this
Subscription Agreement.

 

    4

    Confidential

    

 

d. The
Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make
an investment decision with respect to the Shares, including, with respect to SRAC, the Transaction and the business of the Company
and its subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that he, she or it has reviewed
SRAC’s filings with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s professional
advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the
Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Shares.

 

e. The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and SRAC, the Company
or a representative of SRAC or the Company, and the Shares were offered to the Investor solely by direct contact between the Investor
and SRAC, the Company or a representative of SRAC or the Company. The Investor did not become aware of this offering of the Shares,
nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered
by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering
under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it
is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation
(including, without limitation, SRAC, the Company, the Placement Agents (defined below), any of their respective affiliates or
any control persons, direct or indirect equityholders, officers, managers, directors, employees, consultants, partners, agents
or representatives of any of the foregoing), other than the representations and warranties of SRAC contained in Section 5
of this Subscription Agreement, in making its investment or decision to invest in SRAC.

 

f. The
Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including
those set forth in SRAC’s filings with the SEC. The Investor has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting,
legal and tax advice as the Investor has considered necessary to make an informed investment decision.

 

g. Alone,
or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment
in the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time
and in the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in SRAC. The Investor
acknowledges specifically that a possibility of total loss exists. The Investor is able to sustain a complete loss on its investment
in the Shares, has no need for liquidity with respect to its investment in the Shares and has no reason to anticipate any change
in circumstances, financial or otherwise, which may cause or require any sale or distribution of all or any part of the Shares.

 

h. In making its
decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor. Without
limiting the generality of the foregoing, the Investor has not relied on any statements or other information provided by or
on behalf of either Placement Agent or any of their respective affiliates or any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing concerning SRAC, the Company, the Transaction, the
Transaction Agreement, this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the
offer and sale of the Shares.

 

i. The
Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the
Shares or made any findings or determination as to the fairness of this investment.

 

j. The
Investor, if not an individual, has been duly formed or incorporated and is validly existing and is in good standing under the
laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations
under this Subscription Agreement.

 

    5

    Confidential

    

 

k. The
execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have
been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation
of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the
Investor is a party or by which the Investor is bound, and, if the Investor is not an individual, will not violate any provisions
of the Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws,
indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is
genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same or, if the
Investor is not an individual, the signatory has been duly authorized to execute the same, and this Subscription Agreement constitutes
a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as
may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other
laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

l. The
Investor is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by
the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”)
or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC
List”), or a person or entity prohibited by any OFAC sanctions program, (ii) owned, directly or indirectly, or
controlled by, or acting on behalf of, one or more persons that are named on the OFAC List; (iii) organized, incorporated, established,
located, resident or born in, or a citizen, national or the government, including any political subdivision, agency or instrumentality
thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine or any other country or territory embargoed or subject
to substantial trade restrictions by the United States, (iv) a Designated National as defined in the Cuban Assets Control Regulations,
31 C.F.R. Part 515, or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. The Investor
agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the
Investor is permitted to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act
(31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001 and its implementing regulations (collectively, the
“BSA/PATRIOT Act”), the Investor maintains policies and procedures
reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. If the Investor is an entity, the Investor
also represents and warrants that it maintains policies and procedures reasonably designed to ensure compliance with OFAC-administered
sanctions programs, including for the screening of its investors against the OFAC sanctions programs, including the OFAC List.
Investor further represents and warrants that, to the extent required by applicable law, the Investor maintains policies and procedures
reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived.

 

m. The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under
Section 406 of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), Section 4975 of the
Internal Revenue Code of 1986, as amended (the “Code”), or any other federal, state, local, non-U.S. or other
laws or regulations that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws”).

 

n. If Investor is,
or is acting (directly or indirectly) on behalf of, an employee benefit plan that is subject to Title I of ERISA, a plan,
individual retirement account or other arrangement that is subject to Section 4975 of the Code or an employee benefit plan
that is a governmental plan (as defined in Section 3(32) of ERISA), a church plan (as defined in Section 3(33) of ERISA), a
non-U.S. plan (as described in Section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing but may be
subject to provisions under any Similar Law, or an entity whose underlying assets are considered to include “plan
assets” of any such plan, account or arrangement (each, a “Plan”) subject to the fiduciary or
prohibited transaction provisions of ERISA or Section 4975 of the Code, then the Investor represents and warrants that (i) it
has notified SRAC in writing of its status as a Plan and will provide such additional information as may be requested by the
Company in connection therewith, (ii) none of SRAC, the Company nor any of their respective employees, representatives or
affiliates (the “Transaction Parties”) has acted as the Plan’s fiduciary with respect to its
decision to acquire and hold the Shares, and (iii) none of the Transaction Parties has provided any advice or recommendation,
including, without limitation, in a fiduciary capacity, with respect to its decision to acquire and hold the Shares.

 

    6

    Confidential

    

 

o. No
foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state
have a substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in SRAC as a result of the
purchase and sale of Shares hereunder such that a declaration to the Committee on Foreign Investment in the United States would
be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over
SRAC from and after the Closing as a result of the purchase and sale of Shares hereunder.

 

p. No
disclosure or offering document has been prepared by Evercore Group, L.L.C., Cantor Fitzgerald &
Co. or any of their respective affiliates (collectively, the “Placement Agents”)
in connection with the offer and sale of the Shares.

 

q. Neither
Placement Agent, nor any of its respective affiliates nor any control persons, officers, directors, employees, partners, agents
or representatives of any of the foregoing have made any independent investigation with respect to SRAC, the Company or its subsidiaries
or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any information supplied to the
Investor by SRAC.

 

r. In
connection with the issue and purchase of the Shares, neither Placement Agent has acted as the Investor’s financial advisor
or fiduciary.

 

s. The
Investor has or has commitments to have and, when required to deliver payment to SRAC pursuant
to Section 2 above, will have, sufficient funds to pay the Subscription Amount and consummate the purchase and sale of the
Shares pursuant to this Subscription Agreement.

 

t. As
of the date hereof and as of the Closing Date, the Investor represents that no disqualifying event described in Rule 506(d)(1)(i-viii)
of the Securities Act (a “Disqualification Event”) is applicable to the Investor or any of its Rule 506(d) Related
Parties (as defined below), except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3)
is applicable. The Investor hereby agrees that it shall notify SRAC promptly in writing in the event a Disqualification Event becomes
applicable to the Investor or any of its Rule 506(d) Related Parties at or prior to the Closing, except, if applicable, for a Disqualification
Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable. For purposes of this paragraph (t), “Rule 506(d) Related
Party” shall mean a person or entity that is a beneficial owner of the Investor’s securities for purposes of Rule 506(d)
of the Securities Act.

 

u. The
Investor agrees that, from the date of this Subscription Agreement, none of the Investor nor any person or entity acting on behalf
of the Investor or pursuant to any understanding with the Investor will engage in any Short Sales with respect to securities of
SRAC prior to the Closing. For the purposes hereof, “Short Sales” shall include, without limitation, all “short
sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect
stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts,
options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through
non-U.S. broker dealers or foreign regulated brokers. Notwithstanding the foregoing, nothing herein shall prohibit other entities
under common management with the Investor that have no knowledge of this Subscription Agreement or of Investor’s participation
in this transaction (including the Investor’s controlled affiliates and/or affiliates) from entering into any Short Sales.

 

    7

    Confidential

    

 

7. Registration
Rights.

 

a. In
the event that the Shares are not registered in connection with the consummation of the Transaction, SRAC agrees that, within thirty
(30) calendar days after the Closing Date, SRAC will file with the SEC (at its sole cost and expense) a registration statement
registering the resale of the Shares (the “Registration Statement”),
and it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable
after the filing thereof, but no later than the earlier of (i) the 60th calendar day following the filing date (or the 90th calendar
day if the SEC notifies SRAC (orally or in writing) that it will “review” the Registration Statement) and (ii) the
5th business day after the date SRAC is notified (orally or in writing) by the SEC that the Registration Statement will not be
“reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Date”);
provided, however, that if such date falls on a Saturday, Sunday or other day that the SEC is closed for business,
such date shall be extended to the next business day on which the SEC is open for business. SRAC agrees to cause such Registration
Statement, or another shelf registration statement that includes the Shares to be sold pursuant to this Subscription Agreement,
to remain effective until the earliest of (a) the second anniversary of the Effectiveness Date, (b) the date on which the Investor
ceases to hold any Shares issued pursuant to this Subscription Agreement, and (c) the first date on which the Investor is able
to sell all of its Shares issued pursuant to this Subscription Agreement (or shares received in exchange therefor) under Rule 144
of the Securities Act without limitation as to the amount of such securities that may be sold. The Investor agrees to disclose
its ownership to SRAC upon request to assist it in making the determination described above. SRAC may amend the Registration Statement
so as to convert the Registration Statement to a Registration Statement on Form S-3 at such time after SRAC becomes eligible to
use such Form S-3. The Investor acknowledges and agrees that SRAC may suspend the use of any such registration statement if it
determines that in order for such registration statement not to contain a material misstatement or omission, an amendment thereto
would be needed to include information that would at that time not otherwise be required in a current, quarterly, or annual report
under the Exchange Act; provided, that, (i) SRAC shall not so suspend the use of the Registration Statement for a period
of more than sixty (60) consecutive days, (ii) SRAC may suspend the use of the Registration Statement hereunder only once in any
twelve (12)-month period and (iii) SRAC shall use commercially reasonable efforts to make such Registration Statement available
for the sale by the Investors of the Shares as soon as practicable thereafter.

 

b. If
the SEC prevents SRAC from including any or all of the Shares proposed to be registered for resale under the Registration Statement
due to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable shareholders or
otherwise, (i) such Registration Statement shall register for resale such number of Shares which is equal to the maximum number
of Shares as is permitted by the SEC and (ii) the number of Shares to be registered for each selling shareholder named in the Registration
Statement shall be reduced pro rata among all such selling shareholders. In no event shall the Investor be identified as a statutory
underwriter in the Registration Statement unless requested by the SEC; provided, that if the SEC requests that the Investor
be identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw from
the Registration Statement.

 

c. SRAC’s
obligations to include the Shares issued pursuant to this Subscription Agreement for resale in the Registration Statement are contingent
upon the Investor furnishing in writing to SRAC such information regarding the Investor, the securities of SRAC held by the Investor
and the intended method of disposition of such Shares, which shall be limited to non-underwritten public offerings, as shall be
reasonably requested by SRAC to effect the registration of such Shares, and shall execute such documents in connection with such
registration as SRAC may reasonably request that are customary of a selling stockholder in similar situations.

 

d. SRAC shall,
notwithstanding any termination of this Subscription Agreement, indemnify, defend and hold harmless Investor (to the extent a
seller under the Registration Statement), the officers, directors and agents of Investor, and each person who controls
Investor (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) to the fullest extent
permitted by applicable law, from and against any and all out-of-pocket losses, claims, damages, liabilities, costs
(including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”),
as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in
the Registration Statement, any prospectus included in the Registration Statement or any form of prospectus or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of
any prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not
misleading, or (ii) any violation or alleged violation by SRAC of the Securities Act, Exchange Act or any state securities
law or any rule or regulation thereunder, in connection with the performance of its obligations under this Section 7,
except to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged
omissions are based upon information regarding Investor furnished in writing to SRAC by Investor expressly for use therein or
Investor has omitted a material fact from such information or otherwise violated the Securities Act, Exchange Act or any
state securities law or any rule or regulation thereunder; provided, however, that the indemnification contained in
this Section 7 shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the
consent of SRAC (which consent shall not be unreasonably withheld, conditioned or delayed), nor shall SRAC be liable for any
Losses to the extent they arise out of or are based upon a violation which occurs (A) in reliance upon and in conformity with
written information furnished by Investor, (B) in connection with any failure of such person to deliver or cause to be
delivered a prospectus made available by SRAC in a timely manner or (C) in connection with any offers or sales effected by or
on behalf of Investor in violation of Section 7(d) hereof. SRAC shall notify Investor promptly of the institution,
threat or assertion of any proceeding arising from or in connection with the transactions contemplated by this Section
7 of which SRAC is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or
on behalf of an indemnified party and shall survive the transfer of the Shares by Investor.

 

    8

    Confidential

    

 

e. Investor
shall indemnify and hold harmless SRAC, its directors, officers, agents and employees, and each person who controls SRAC (within
the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), to the fullest extent permitted by applicable
law, from and against all Losses, as incurred, (i) arising out of or based upon any untrue or alleged untrue statement of a material
fact contained in any Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus,
or in any amendment or supplement thereto or in any preliminary prospectus, or (ii) arising out of or relating to any omission
or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of
any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not
misleading, with respect to (i) and/or (ii), to the extent, but only to the extent, that such untrue or alleged untrue statements
or omissions or alleged omissions are based upon information regarding Investor furnished in writing to SRAC by Investor expressly
for use therein (and for the avoidance of doubt, not to the extent based upon information regarding any other investor that is
party to any of the other subscription agreements related to the private placement of the Shares); provided, however, that
the indemnification contained in this Section 7(e) shall not apply to amounts paid in settlement of any Losses if such settlement
is effected without the consent of Investor (which consent shall not be unreasonably withheld, conditioned or delayed). In no event
shall the liability of Investor be greater in amount than the dollar amount of the net proceeds received by Investor upon the sale
of the Shares giving rise to such indemnification obligation. Investor shall notify SRAC promptly of the institution, threat or
assertion of any proceeding arising from or in connection with the transactions contemplated by this Section 7(e) of which
Investor is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of
an indemnified party and shall survive the transfer of the Shares by Investor.

 

f. With
a view to making available to the Investor the benefits of Rule 144 of the Securities Act that may at any time following the Closing
Date permit the Investor to sell its Shares to the public without registration. SRAC agrees, until the second anniversary of the
Effectiveness Date, to:

 

(i) make
and keep public information available, as those terms are understood and defined in Rule 144 of the Securities Act;

 

(ii) file
with the SEC in a timely manner all reports and other documents required of SRAC under the Securities Act and the Exchange Act
for so long as SRAC remains subject to such requirements and the filing of such reports and other documents is required for the
applicable provisions of Rule 144 of the Securities Act; and

 

(iii)
furnish to the Investor so long as it owns its Shares, within two (2) business days following its receipt of a written
request therefor from the Investor, (x) a written statement by SRAC, if true, that it has complied with the reporting
requirements of Rule 144 of the Securities Act, the Securities Act and the Exchange Act, (y) a copy of the most recent annual
or quarterly report of SRAC filed with the SEC and such other reports and documents so filed with the SEC by SRAC and (z)
such other information as may be reasonably requested in writing to permit the Investor to sell such securities pursuant to
Rule 144 without registration (to the extent readily available and consistent with SRAC’s internal policies and
procedures).

 

8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of
the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier
to occur of (a) such date and time as the Transaction Agreement is terminated in accordance with its terms without being consummated,
(b) upon the mutual written agreement of each of the parties hereto and the Company to terminate this Subscription Agreement,
(c) 30 days after the Outside Date (as defined in the Transaction Agreement), if the Closing has not occurred by such date, or
(d) by written notice of the Investor to SRAC in the event the Transaction Agreement is amended, supplemented or otherwise modified
after the date hereof in a manner that materially adversely affects the Investor (the termination events described in clauses
(a)–(d) above, collectively, the “Termination Events”); provided that nothing herein will relieve
any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any
remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach. SRAC shall notify
the Investor in writing of the termination of the Transaction Agreement promptly after the termination of such agreement. Upon
the occurrence of any Termination Event, this Subscription Agreement shall be void and of no further effect and any monies paid
by the Investor to SRAC in connection herewith shall promptly (and in any event within one business day) following the Termination
Event be returned to the Investor.

 

    9

    Confidential

    

 

9. Trust Account
Waiver. The Investor acknowledges that SRAC is a blank check company with the powers and privileges to effect a merger, asset
acquisition, reorganization or similar business combination involving SRAC and one or more businesses or assets. The Investor
further acknowledges that, as described in SRAC’s prospectus relating to its initial public offering dated November 7, 2019
(the “Prospectus”) available at www.sec.gov, substantially all of
SRAC’s assets consist of the cash proceeds of SRAC’s initial public offering and private placement of its securities,
and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of SRAC, its public shareholders and the underwriters of SRAC’s initial public
offering. Except with respect to interest earned on the funds held in the Trust Account that may be released to SRAC to pay its
tax obligations, if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. For
and in consideration of SRAC entering into this Subscription Agreement, the receipt and sufficiency of which are hereby acknowledged,
the Investor hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have in the
future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account, regardless of
whether such claim arises as a result of, in connection with or relating in any way to, this Subscription Agreement or any other
matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of liability (the “Released
Claims”); provided, that the Released Claims shall not include any claims that the Investor may have solely in
the Investor’s capacity as a record or beneficial holder of any Shares other than the Shares purchased by it pursuant to
this Subscription Agreement.

 

10. Miscellaneous.

 

a. Neither
this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares acquired hereunder,
if any) may be transferred or assigned without the prior written consent of each of the other parties hereto; provided that this
Subscription Agreement and any of the Investor’s rights and obligations hereunder may be assigned to any fund or account
managed by the same investment manager as the Investor or by an affiliate of such investment manager without the prior consent
of SRAC; provided further that (x) prior to such assignment any such assignee shall agree in writing to be bound by the
terms hereof and (y) no such assignment shall relieve the Investor of its obligations hereunder if any such assignee fails to fully
perform such obligations.

 

b. SRAC
may request from the Investor such additional information as SRAC may reasonably deem necessary to register the resale of the Shares
and evaluate the eligibility of the Investor to acquire the Shares, and the Investor shall provide such information as may reasonably
be requested to the extent readily available and to the extent consistent with its internal policies and procedures; provided that
SRAC expressly agrees to keep any such information provided by the Investor confidential. The Investor acknowledges that SRAC may
file a copy of this Subscription Agreement with the SEC as an exhibit to a periodic report or a registration statement of SRAC.

 

c. The
Investor acknowledges that SRAC, the Company, the Placement Agents and others will rely on the acknowledgments, understandings,
agreements, representations and warranties contained in this Subscription Agreement. Prior to the Closing, each party hereto agrees
to promptly notify the other party hereto if any of the acknowledgments, understandings, agreements, representations and warranties
set forth herein with respect to it are no longer accurate. Each party hereto further acknowledges and agrees that each purchase
by the Investor, and each sale by SRAC, of Shares will constitute a reaffirmation of their respective acknowledgments, understandings,
agreements, representations and warranties herein (as modified by any such notice) as of the time of such purchase and sale.

 

d. SRAC,
the Company and the Placement Agents are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized
to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official
inquiry with respect to the matters covered hereby to the extent required by law or regulatory bodies; provided, however,
that the foregoing clause of this Section 10(d) shall not give the Company or the Placement Agents any rights other than
those expressly set forth herein and, without limiting the generality of the foregoing and for the avoidance of doubt, in no event
shall the Company be entitled to rely on any of the representations and warranties of SRAC set forth in this Subscription Agreement.

 

    10

    Confidential

    

 

e. All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

f. This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above) except
by an instrument in writing, signed by each of the parties hereto, provided, however, that no modification or waiver by
SRAC of the provisions of this Subscription Agreement shall be effective without the prior written consent of the Company (other
than modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or any
other material term of this Subscription Agreement). No failure or delay of either party in exercising any right or remedy hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance
of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise
of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights
or remedies that they would otherwise have hereunder.

 

g. This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements,
understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof.
Except as set forth in Section 8, Section 10(c), Section 10(d), Section 10(f), this Section 10(g),
the last sentence of Section 10(k) and Section 11 with respect to the persons specifically referenced therein, this
Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective
successor and assigns, and the parties hereto acknowledge that such persons so referenced are third party beneficiaries of this
Subscription Agreement for the purposes of, and to the extent of, the rights granted to them, if any, pursuant to the applicable
provisions.

 

h. Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

i. If any provision
of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or
unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not
in any way be affected or impaired thereby and shall continue in full force and effect.

 

j. This
Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail or in .pdf) and by
different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

k. The
parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to seek an injunction or injunctions to prevent breaches or threatened breaches of this Subscription
Agreement, without posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions
of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in
contract, in tort or otherwise. The right to specific enforcement shall include the right of each party hereto to cause the other
party hereto to cause the transactions contemplated hereby to be consummated on the terms and subject to the conditions and limitations
set forth in this Subscription Agreement.

 

l. This
Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (regardless of the
laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters (including any action,
suit, litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit, investigation or reviews
by or before any governmental entity related hereto), including matters of validity, construction, effect, performance and remedies

 

    11

    Confidential

    

 

m. Each party hereto
and any person asserting rights as a third party beneficiary may do so only if he, she or it irrevocably agrees that any action,
suit or proceeding between or among the parties hereto, whether arising in contract, tort or otherwise, arising in connection
with any disagreement, dispute, controversy or claim arising out of or relating to this Subscription Agreement or any related
document or any of the transactions contemplated hereby or thereby (“Legal Dispute”) shall be brought only
to the exclusive jurisdiction of the courts of the State of Delaware or the federal courts located in the State of Delaware, and
each party hereto hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any
such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now
or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action
or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period a Legal Dispute that
is filed in accordance with this Section 10(m) is pending before a court, all actions, suits or proceedings with respect
to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be subject to
the exclusive jurisdiction of such court. Each party hereto and any person asserting rights as a third party beneficiary may do
so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (i) such party is not
personally subject to the jurisdiction of the above named courts for any reason, (ii) such action, suit or proceeding may
not be brought or is not maintainable in such court, (iii) such party’s property is exempt or immune from execution,
(iv) such action, suit or proceeding is brought in an inconvenient forum, or (v) the venue of such action, suit or proceeding
is improper. A final judgment in any action, suit or proceeding described in this Section 10(m) following the expiration
of any period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by applicable Laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING
RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL
BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH
THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT
IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE
ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

n. The
Investor hereby consents to the publication and disclosure in any Form 8-K filed by SRAC with the SEC in connection with the execution
and delivery of the Transaction Agreement or the transactions contemplated thereby and the Registration Statement (as defined in
the Transaction Agreement) (and, to the extent otherwise required by the federal securities laws, exchange rules, the SEC or any
other securities authorities or any rules and regulations promulgated thereby, any other documents or communications provided by
SRAC or the Company to any governmental entity or to any securityholders of SRAC or the Company) of the Investor’s identity
and beneficial ownership of the subscribed Shares and the nature of the Investor’s commitments, arrangements and understandings
under and relating to this Subscription Agreement and, if deemed appropriate by SRAC or the Company, a copy of this Subscription
Agreement, all solely to the extent required by applicable law or any regulation or stock exchange listing requirement. The Investor
will promptly provide any information reasonably requested by SRAC or the Company for any regulatory application or filing made
or approval sought in connection with the Transaction (including filings with the SEC).

 

    12

    Confidential

    

 

o. SRAC
shall, by 9:30 a.m., New York City time, on the first (1st) business day immediately following the date of this Subscription Agreement,
issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”)
disclosing, to the extent not previously publicly disclosed, all material terms of the transactions contemplated hereby (and of
the other subscription agreements related to the private placement of the Shares entered into prior to the release or filing of
such Disclosure Document), the Transaction and any other material, non-public information that SRAC or the Company has provided
to the Investor at any time prior to the filing of the Disclosure Document. As of immediately following the filing of the Disclosure
Document with the SEC, to the knowledge of SRAC, the Investor shall not be in possession of any material, non-public information
received from SRAC, the Company, any of their respective subsidiaries or any of their respective officers, directors, employees,
affiliates or agents that is not disclosed in the Disclosure Document or in prior filings with the SEC. In addition, effective
upon the filing of the Disclosure Document, SRAC acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between SRAC, on the one hand, and the Investor or any of its affiliates, on the
other hand, shall terminate and be of no further force or effect.

 

p. If
any change in the number, type or classes of authorized shares of SRAC (including the Shares) shall occur between the date hereof
and immediately prior to the Closing by reason of reclassification, recapitalization, stock split (including reverse stock split)
or combination, exchange or readjustment of shares, or any stock dividend, the number of Shares issued to the Investor shall be
appropriately adjusted to reflect such change.

 

11. Non-Reliance.
The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made
by any person, firm or corporation (including, without limitation, the Company, the Placement
Agents, any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or
representatives of any of the foregoing), other than the statements, representations and warranties of SRAC expressly contained
in Section 5 of this Subscription Agreement, in making its investment or decision to invest in SRAC.

 

[SIGNATURE PAGES FOLLOW]

 

    13

    Confidential

    

 

IN WITNESS WHEREOF,
the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the
date set forth below.

 

	
        Name of Investor:
	State/Country of Formation or Domicile:
	 	 
	By:  _____________________________________	 
	Name:  ___________________________________	 
	Title:  ___________________________________	 
	 	 
	Name in which Shares are to be registered (if different):	Date: ________, 2020
	 	 
	Investor’s EIN:	 
	 	 
	Business Address-Street:	Mailing Address-Street (if different):
	 	 
	City, State, Zip:	City, State, Zip:
	 	 
	Attn:  ____________________________________	Attn:  ____________________________________
	 	 
	Telephone No.:	Telephone No.:
	Facsimile No.:	Facsimile No.:
	 	 
	Number of Shares subscribed for:	 
	 	 
	Aggregate Subscription Amount: $	Price Per Share: $10.00

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by SRAC in the Closing
Notice. To the extent the offering is oversubscribed, the number of Shares received may be less than the number of Shares subscribed
for.

 

Signature Page
to Subscription Agreement

 

     

    Confidential

    

 

IN WITNESS WHEREOF,
SRAC has accepted this Subscription Agreement as of the date set forth below.

 

	 	STABLE ROAD ACQUISITION CORP.
	 	 	 
	 	By:	      
	 	Name:	 
	 	Title:	 

 

Date:                    ,
2020

 

Signature Page
to Subscription Agreement

 

     

     

    

 

SCHEDULE A

 

ELIGIBILITY
REPRESENTATIONS OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

	 	(Please check the applicable subparagraphs):

 

☐  We
are a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)).

 

	B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	☐  We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box below indicating the provision under which we qualify as an “accredited investor.”

 

	 	2.    ☐  We are not a natural person.

 

Rule
501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below
listed categories, or who SRAC reasonably believes comes within any of the below listed categories, at the time of the sale of
the securities to that person. The Investor has indicated, by marking and initialing the appropriate box below, the provision(s)
below which apply to the Investor and under which the Investor accordingly qualifies as an “accredited investor.”

 

☐  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business
investment company;

 

☐  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

☐  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company,
or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

☐  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership,
not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

☐  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or

 

☐  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This
page should be completed by the Investor

and
constitutes a part of the Subscription Agreement.Exhibit 10.2

 

Final Form

 

SUPPORT AGREEMENT

 

THIS SUPPORT AGREEMENT
(this “Agreement”) is entered into as of October 7, 2020, by and between Stable Road Acquisition Corp., a Delaware
corporation (“Parent”), and [●] (the “Company Stockholder”). Capitalized terms used
and not defined herein shall have the meanings set forth in the Merger Agreement.

 

RECITALS

 

WHEREAS, it is contemplated
that, pursuant to the Agreement and Plan of Merger, dated as of the date hereof (as amended, modified, supplemented or waived from
time to time in accordance with its terms, the “Merger Agreement”), by and among Parent, Project Marvel First
Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned Subsidiary of Parent (“First Merger Sub”),
Project Marvel Second Merger Sub, LLC, a Delaware limited liability company and a direct wholly-owned Subsidiary of Parent (“Second
Merger Sub”), and Momentus Inc., a Delaware corporation (the “Company”), First Merger Sub shall merge
with and into the Company (the “First Merger”), with the Company being the surviving corporation of the First
Merger (the “Surviving Corporation”), and immediately following the First Merger, as part of the same overall
transaction as the First Merger, the Surviving Corporation will merge with and into Second Merger Sub (the “Second Merger”
and, together with the First Merger, the “Mergers”) with Second Merger Sub being the surviving company of the
Second Merger (the “Surviving Entity”), and as a result of which the Surviving Entity will become a wholly-owned
Subsidiary of Parent;

 

WHEREAS, as of the date
hereof, the Company Stockholder is the record and “beneficial owner” (within the meaning of Rule 13d-3 under the Securities
Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the “Exchange Act”))
of the number of shares of Company Common Stock, Company Preferred Stock, Company FF Preferred Stock, vested Company Restricted
Stock and/or other Company Interests set forth on Schedule 1 attached hereto (and, together with any additional Company
Interests in which the Company Stockholder acquires record and beneficial ownership after the date hereof, including by purchase,
as a result of a stock dividend, stock split, recapitalization, combination, reclassification, exchange or change of such shares,
or upon exercise or conversion of any securities, the “Equity Securities”);

 

WHEREAS, the Company
Stockholder will receive substantial benefits from the consummation of the transactions contemplated by the Merger Agreement;

 

WHEREAS, the representations,
warranties, covenants and other agreements set forth herein were a material inducement to Parent to enter into the Merger Agreement
and to perform its obligations thereunder; and

 

WHEREAS, Parent is relying
on the representations, warranties, covenants and other agreements of this Agreement and Parent would not enter into the Merger
Agreement or be willing to consummate the Mergers without the representations, warranties, covenants and other agreements of this
Agreement.

 

     

     

    

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the foregoing and the representations, warranties, covenants and agreements contained herein, and intending to be legally bound
hereby, the parties hereto hereby agree as follows:

 

1. Voting;
Waiver of Appraisal Rights; Waiver of Transfer Restrictions. Subject to the earlier termination of this Agreement in accordance
with Section 2, the Company Stockholder, solely in their capacity as a holder of the Equity Securities, agrees as follows:
(a) the Company Stockholder hereby irrevocably and unconditionally waives and agrees not to exercise or assert, or make any demand
in respect of, any rights of appraisal, any dissenters’ rights and any similar rights relating to the Mergers or any other
transaction contemplated by the Merger Agreement that the Company Stockholder may have (under Section 262 of DGCL, Chapter 13 of
the CCC or otherwise) by virtue of, or with respect to, any outstanding Company Stock owned of record or beneficially by the Company
Stockholder; (b) the Company Stockholder will, with respect to all of the Company Stockholder’s Equity Securities, vote at
any meeting of the stockholders of the Company, and in any action by written consent of the stockholders of the Company, to approve
and adopt the Merger Agreement and the transactions contemplated thereby, including the Mergers, and will not withdraw or rescind
such vote or otherwise take action to make such vote ineffective, and in furtherance thereof, within three (3) Business Days of
the Registration Statement becoming effective, the Company Stockholder will execute and deliver the Stockholder Written Consent
in accordance with the terms and conditions set forth in the Merger Agreement, and will not thereafter withdraw or rescind such
consent or otherwise take action to make such consent ineffective; and (c) promptly following the Effective Time and in accordance
with the terms and conditions set forth in the Merger Agreement, the Company Stockholder will execute and deliver a Letter of Transmittal,
in a customary form, for all of the Company Stockholder’s Equity Securities. In addition, in accordance with Section 10 of
that certain Amended and Restated First Refusal and Co-Sale Agreement, dated as of June 21, 2019, as amended, including on September
30, 2019, by and among the Company and certain of the holders of Company Stock (the “ROFR/Co-Sale Agreement”),
the Company Stockholder hereby agrees to waive the provisions of Section 2 of the ROFR/Co-Sale Agreement with respect to the Merger
Agreement and the Transactions, including the Mergers.

 

2. Termination.

 

(a) Subject
to Section 2(b), this Agreement shall terminate upon the earliest of: (i) the Effective Time; (ii) the termination of the
Merger Agreement in accordance with its terms; and (iii) the time this Agreement is terminated upon the mutual written agreement
of Parent and the Company Stockholder (the earliest such date under clause (i), (ii) and (iii) being referred to herein as the
“Termination Date”).

 

(b) Upon
termination of this Agreement, no party hereto shall have any further obligations or liabilities under this Agreement; provided,
that the provisions set forth in Section 5, Section 6(a), Section 6(c) (in each of the foregoing cases, solely
in the case of termination under clause (i) of Section 2(a)), Section 6(b), Section 6(d) and Section 7
shall survive the termination of this Agreement; provided, further, that termination of this Agreement shall not
relieve any party hereto from any liability for any intentional breach of this Agreement prior to such termination.

 

(c) The
representations and warranties contained in this Agreement and in any certificate or other writing delivered pursuant hereto shall
not survive the Closing or the termination of this Agreement.

 

3. Representations
and Warranties of the Company Stockholder.

 

(a) The
Company Stockholder hereby represents and warrants to Parent that the Equity Securities set forth on Schedule 1 attached
hereto constitute all of the shares of Company Common Stock, Company Preferred Stock, Company FF Preferred Stock, vested Company
Restricted Stock and other Company Interests owned of record or beneficially by the Company Stockholder as of the date hereof.
The Company Stockholder has good and valid title to such Equity Securities set forth on Schedule I attached hereto and as
of the Effective Time will have good and valid title to such Equity Securities held by the Company Stockholder set forth on Schedule
I attached hereto free and clear of all Liens (other than transfer restrictions under applicable securities Laws).

 

    2

     

    

 

(b) [(A)
The Company Stockholder has all requisite capacity to execute and deliver this Agreement and the Transaction Agreements to which
it is a party and to perform its obligations hereunder and thereunder and to consummate the Transactions,] // [(A) The Company
Stockholder is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation or organization
and has the requisite corporate, limited liability company or other entity power and authority, as applicable, to execute and deliver
this Agreement and to perform its obligations hereunder,] [(B) the execution, delivery and performance by the Company Stockholder
of this Agreement and its obligations hereunder have been duly and validly authorized by the Company Stockholder and no other act
or proceeding on the part of the Company Stockholder is necessary to authorize the execution, delivery or performance of this Agreement,]
([C]) this Agreement has been duly executed and delivered by the Company Stockholder and, assuming the due authorization,
execution and delivery by each other party hereto, constitutes a valid and binding obligation of the Company Stockholder, enforceable
in accordance with its terms, subject to the Remedies Exception, and ([D]) neither the execution and delivery of this Agreement
nor the consummation of the transactions contemplated hereby will [(i) conflict with or result in any material breach of any
provision of the Charter Documents of the Company Stockholder,] ([ii]) require any material filing with, or the obtaining of any
material consent or material approval of, any Governmental Entity by the Company Stockholder (other than the filings, notices and
reports pursuant to, in compliance with or required to be made under the Exchange Act and other than those set forth as conditions
to closing in the Merger Agreement), or [(iii)] violate in any material respect any material Law applicable to the Company
Stockholder, except, in the case of the foregoing clauses [(ii) and (iii)], for violations which would not, individually
or in the aggregate, reasonably be expected to prevent or delay the consummation of the transactions contemplated by this Agreement.

 

4. Merger
Agreement Obligations.

 

(a) Other
than as expressly permitted by the Merger Agreement or the other Transaction Agreements, until the Termination Date, the Company
Stockholder will not, directly or indirectly, (i) sell, transfer, assign, tender in any tender or exchange offer, pledge,
encumber, hypothecate or similarly dispose of (by merger, by testamentary disposition, by operation of law or otherwise), either
voluntarily or involuntarily, or enter into any Contract, option or other arrangement or understanding with respect to the sale,
transfer, assignment, Lien, hypothecation or similar disposition of (by merger, by testamentary disposition, by operation of law
or otherwise), any of its Equity Securities, (ii) deposit any Equity Securities into a voting trust or enter into a voting
agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with this Agreement
(other than any Contracts set forth on Section 7.18 of the Company Disclosure Letter entered into prior to the date hereof and
to be terminated contingent upon and automatically effective as of the Closing in accordance with Section 6(c)), or (iii) agree
(whether or not in writing) to take any of the actions referred to in the foregoing clause (i) or (ii) of this
Section 4; provided, however, that nothing herein shall prohibit the Company Stockholder from transferring
Equity Securities to an Affiliate of such Company Stockholder or, if the Company Stockholder is an individual, to any member of
the Company Stockholder’s immediate family or to a trust solely for the benefit of the Company Stockholder or any member
of the Company Stockholder’s immediate family; provided, that (x) any such transfers shall be permitted only if, as
a precondition to such transfer, the transferee agrees in a writing, reasonably satisfactory in form and substance to Parent, to
assume all of the obligations of the Company Stockholder under, and to be bound by all of the terms of, this Agreement and (7)
any such permitted transfer shall not relieve the Company Stockholder of its obligations under this Agreement.

 

    3

     

    

 

(b) Until
the Termination Date, the Company Stockholder hereby agrees to be bound by the terms and conditions set forth in the first sentence
of Section 7.8(c) (Confidentiality; Communications Plan; Access to Information), Section 7.1 (Company No Solicitation), Section
7.11 (No Claim Against Trust Account) and, to the extent applicable to any of the foregoing, the remaining provisions of Article
XI (General Provisions) of the Merger Agreement (and any relevant definitions used in such Sections) fully and to the same extent
as if the Company Stockholder was a party and signatory to such provisions of the Merger Agreement.

 

(c) Notwithstanding
anything in this Agreement to the contrary: (i) the Company Stockholder shall not be responsible for the actions of the Company
or the Company board of directors (or any committee thereof), or any officers, directors (in their capacity as such), employees
and professional advisors of any of the foregoing (the “Company Related Parties”), with respect to any of the
matters contemplated by Section 4(b); (ii) the Company Stockholder makes no representations or warranties with respect to
the actions of any of the Company Related Parties; and (iii) any breach by the Company of its obligations under Section 7.1 
of the Merger Agreement shall not, in and of itself, be considered a breach of Section 4(b) (it being understood for the
avoidance of doubt that the Company Stockholder shall remain responsible for any breach by it or its Representatives (other than
any such Representative that is a Company Related Party) of Section 4(b)).

 

5. General
Waiver and Release.

 

(a) Effective
as of, and contingent upon, the consummation of the Closing, the Company Stockholder, on behalf of itself and any of its heirs,
executors, beneficiaries, administrators, successors, assigns, controlled Affiliates and any other Person or entity claiming by,
through or under any of the foregoing (each, a “Releasor”), hereby forever, unconditionally and irrevocably
acquits, remises, discharges and releases, effective as of the Closing, the Company and its Affiliates (including, after the Closing,
Parent, First Merger Sub, Second Merger Sub, the Surviving Entity and each of their respective Affiliates), each of their respective
officers, directors, equityholders, employees, partners, trustees and Representatives, and each successor and assign of any of
the foregoing (collectively, the “Releasees”) from any and all claims, demands, charges, complaints, causes
of action, damages, costs, expenses, obligations, losses, rights, suits, accountings, orders, judgments, obligations, agreements
and liabilities of every kind and character whatsoever, whether accrued or fixed, absolute or contingent, matured or unmatured,
suspected or unsuspected or determined or determinable, and whether at law or in equity, that any Releasee may have to such Releasor
(or that any Releasor may have against any Releasee), in any capacity, whether directly or derivatively through another Person,
arising contemporaneously with or prior to the Closing; provided that liabilities and obligations acquitted, remised, discharged
and released pursuant to this Section 5(a) (collectively, the “Released Claims”) shall not include (A)
any rights of the Releasors under this Agreement, the Merger Agreement and the other Transaction Agreements, (B) if such Releasor
is an employee of the Company, rights to earned but unpaid wages or other compensation or benefits and rights under any written
employment agreements with or benefit plans of the Company in existence as of the date hereof, (C) any rights to indemnification,
exculpation and/or advancement of expenses (whether pursuant to the Charter Documents of the Company, any insurance policy or any
other agreement entered into with the Company) for serving as an officer, director, manager, agent or employee of the Company,
in each case existing prior to Closing, or (D) any rights as a third-party beneficiary to indemnification, exculpation and/or advancement
of expenses set forth in the Indemnification Agreement by and between the Company and Dakin Sloss, dated November 1, 2018, in each
case existing prior to Closing. Further, the Company Stockholder, on behalf of itself and the Releasors, hereby irrevocably covenants
to refrain from, directly or indirectly, asserting any Released Claim, or threatening, commencing, instituting or causing to be
commenced, any proceeding of any kind against any Releasee based upon any Released Claim. Without limiting the foregoing, the Company
Stockholder, on behalf of itself and each Releasor, understands and agrees that the claims released in this Section 5(a),
if and when released, include not only claims presently known but also include all unknown or unanticipated claims, obligations,
liabilities, charges, demands, and causes of action of every kind and character that would otherwise come within the scope of the
Released Claims.

 

    4

     

    

 

(b) Effective
as of, and contingent upon, the consummation of the Closing, the Company Stockholder, on behalf of itself and each Releasor, knowingly
and voluntarily waives and releases any and all rights and benefits he, she or it may not have, or in the future may have, under
Section 1542 of the California Civil Code (“Section 1542”) or any analogous state law or federal law, which
reads as follows:

 

“A GENERAL RELEASE DOES NOT EXTEND
TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING
THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED
PARTY.”

 

The Company Stockholder,
on behalf of itself and each Releasor, understands that Section 1542, or a comparable statute, rule, regulation or order of another
jurisdiction, gives such the Company Stockholder the right not to release existing claims of which the Company Stockholder is not
aware, unless the Company Stockholder voluntarily chooses to waive this right. Having been so apprised, the Company Stockholder,
on behalf of itself and each Releasor, nevertheless hereby voluntarily elects to and does waive the rights described in Section
1542, or such other comparable statute, rule, regulation or order, and elects to assume all risks for claims that exist, existed
or may hereafter exist in its favor, known or unknown, suspected or unsuspected, arising out of or related to claims or other matters
purported to be released pursuant to this Section 5, in each case, effective at the Closing. The Company Stockholder, on
behalf of itself and each Releasor, acknowledges and agrees that the foregoing waiver is an essential and material term of the
release provided pursuant to this Section 5 and that, without such waiver, Parent would not have agreed to the terms of
this Agreement.

 

6. Covenants.

 

(a) Further
Assurances. From time to time and without additional consideration, the Company Stockholder shall execute and deliver, or cause
to be executed and delivered, such additional transfers, assignments, endorsements, proxies, consents and other instruments, and
shall take such further actions as Parent may reasonably request for the purpose of carrying out and furthering the intent of this
Agreement. The Company Stockholder further agrees not to commence or participate in, and to take all actions necessary to opt out
of any class in any class action with respect to, any action or claim, derivative or otherwise, against Parent, Parent’s
Affiliates, the Sponsor, the Company, the Surviving Entity or any of their respective successors and assigns relating to the negotiation,
execution or delivery of this Agreement, the Merger Agreement (including the Per Share Company Stock Consideration) or the consummation
of the transactions contemplated hereby and thereby.

 

(b) Acknowledgment.
The Company Stockholder acknowledges and agrees that the Company Stockholder is entering
into this Agreement On the Company Stockholder’s own free will and not under any duress or undue influence. THE COMPANY
STOCKHOLDER has entered into this Agreement freely and without coercion, THE COMPANY
STOCKHOLDER has been advised by PARENT to consult with counsel of THE COMPANY STOCKHOLDER’s
choice with regard to the execution of this Agreement and THE COMPANY STOCKHOLDER’s
covenants hereunder, THE COMPANY STOCKHOLDER has had an adequate opportunity to
consult with such counsel and either so consulted or freely determined in THE COMPANY STOCKHOLDER’s
own discretion not to so consult with such counsel, THE COMPANY STOCKHOLDER understands
that PARENT haS been advised by counsel, and THE COMPANY STOCKHOLDER has read this
Agreement AND THE MERGER AGREEMENT and fully and completely understands this Agreement AND THE MERGER AGREEMENT and each of THE
COMPANY STOCKHOLDER’s representations, warranties, covenants and other agreements
hereunder AND THEREUNDER. This Agreement shall be interpreted and construed as having been drafted jointly by THE COMPANY
STOCKHOLDER and PARENT and no presumption or burden of proof shall arise favoring or disfavoring
any party hereto by virtue of the authorship of any or all of the provisions of this Agreement.

 

    5

     

    

 

(c) Consent
to Terminate Certain Agreements. The Company Stockholder hereby consents to the termination, contingent upon and automatically
effective as of the Closing, of all Contracts set forth on Section 7.18 of the Company Disclosure Letter (other than any indemnification
agreements between any D&O Indemnified Party and the Company).

 

(d) Disclosure.
The Company Stockholder hereby authorizes the Company and Parent to publish and disclose in any announcement or disclosure required
by the SEC the Company Stockholder’s identity and ownership of the Equity Securities and the nature of the Company Stockholder’s
obligations under this Agreement; provided, that prior to any such publication or disclosure the Company and Parent have
provided the Company Stockholder with an opportunity to review and comment upon such announcement or disclosure, which comments
the Company and Parent will consider in good faith.

 

7. General
Provisions.

 

(a) Amendment.
This Agreement may not be amended except by an instrument signed by Parent and the Company Stockholder.

 

(b) Notices.
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given (a) when delivered
in person or, by e-mail (so long as such transmission does not generate an error message or notice of non-delivery), (b) on the
next Business Day when sent by overnight courier, or (c) on the second succeeding Business Day when sent by registered or certified
mail (postage prepaid, return receipt requested) to the respective parties at the following addresses (or at such other address
for a party hereto as shall be specified by like notice):

 

		(i)	if to Parent:

 

	Stable Road Acquisition Corp.	 
	1345 Abbot Kinney Blvd	 
	Venice, California 90291	 

	Attention:	Brian Kabot
	 	Juan Quiroga
	E-mail:	brian@stableroadcapital.com
	 	juan@nalainvestments.com

 

    6

     

    

 

with a copy (which shall not
constitute notice to Parent) to:

 

	Kirkland & Ellis LLP	 
	300 North LaSalle Street	 
	Chicago, Illinois  60654	 

	Attention:	Douglas C. Gessner, P.C.
	 	Bradley C. Reed, P.C.
	 	Kevin M. Frank
	E-mail:	douglas.gessner@kirkland.com
	 	bradley.reed@kirkland.com
	 	kevin.frank@kirkland.com

 

		(ii)	if to the Company Stockholder, to the address or
addresses listed on Schedule 1 hereto.

 

with a copy (which shall not
constitute notice to the Company Stockholder) to:

 

	Orrick, Herrington & Sutcliffe LLP	 
	631 Wilshire Blvd, Suite 2-C	 
	Santa Monica, CA 90401	 

	Attention:	Daniel S. Kim
	 	Hari Raman
	 	Albert W. Vanderlaan
	E-mail:	dan.kim@orrick.com
	 	hraman@orrick.com
	 	avanderlaan@orrick.com

 

(c) Interpretation.
Unless the context of this Agreement otherwise clearly requires, (i) references to the plural include the singular, and references
to the singular include the plural, (ii) references to one gender include the other gender, (iii) the words “include”,
“includes,” “including” and words of similar import do not limit the preceding terms or words and shall
be deemed to be followed by the words “without limitation”, (iv) the terms “hereof”, “herein”,
“hereunder”, “hereto” and similar terms in this Agreement refer to this Agreement as a whole and not to
any particular provision of this Agreement, (v) the term “or” will not be deemed to be exclusive, (vi) the word “will”
shall be construed to have the same meaning and effect as the word “shall”, (vii) the terms “day” and “days”
mean and refer to calendar day(s), (viii) the terms “year” and “years” mean and refer to calendar year(s),
(ix) references to any statute shall be deemed to refer to such statute and to any rules or regulations promulgated thereunder,
(x) references to any person include the successors and permitted assigns of that person, and (xi) references from or through any
date mean, unless otherwise specified, from and including such date or through and including such date, respectively. All Section
and Schedule references herein are to Sections and Schedules of this Agreement, unless otherwise specified.

 

(d) Section
Headings; Defined Terms. The Section headings contained in this Agreement are exclusively for the purpose of reference, are
not part of the agreement of the parties and shall not in any way affect the meaning or interpretation of this Agreement. The
defined terms contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation
of this Agreement.

 

(e) Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which taken together
shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile
or e-mail shall be as effective as delivery of a manually executed counterpart of the Agreement. Minor variations in the form of
the signature page, including footers from earlier versions of this Agreement or any such other document, will be disregarded in
determining a party’s intent or the effectiveness of such signature.

 

    7

     

    

 

(f) Entire
Agreement; No Third Party Beneficiaries. The agreement of the parties that is comprised of this Agreement, the Letter of Transmittal
executed by the Company Stockholder and the provisions of the Merger Agreement referenced in Section 4 herein to which the
Company Stockholder has expressly agreed to be bound constitute the entire agreement and understanding among the parties hereto
with respect to the subject matter hereof and thereof and supersedes all other prior agreements, and understandings, whether oral
or written, relating to the subject matter of this Agreement, and is not intended to confer upon any Person other than the parties
hereto any rights or remedies hereunder; provided, however, that the Releasees are express third party beneficiaries
of this Agreement and the Company shall be an express third party beneficiary with respect to Section 4 and Section 6(c)
hereof. For the avoidance of doubt, this Agreement does not and shall not affect any prior understandings, agreements or representations
with respect to any similar subject matter entered into in connection with or as a result of the Company Stockholder’s direct
or indirect ownership of any Company Interests or any provision of services to the Company.

 

(g) Severability.
If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of Law or public
policy, all other terms, conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the transactions contemplated by this Agreement is not affected in any manner materially
adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being
enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the
parties hereto as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement
be consummated as originally contemplated to the fullest extent possible.

 

(h) Binding
Effect; Assignment. This Agreement and all of the provisions hereof shall be binding upon and shall inure to the benefit of
the parties hereto and their respective successors and permitted assigns. Subject to Section 4(a), neither this Agreement
nor any of the rights, interests or obligations hereunder shall be assigned, directly or indirectly, including by operation of
law, by any party hereto without the prior written consent of the other party hereto. Any purported assignment in violation of
this Section 7(h) shall be null and void ab initio.

 

(i) Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (regardless of
the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters (including Legal
Proceedings related hereto), including matters of validity, construction, effect, performance and remedies.

 

    8

     

    

 

(j) Consent
to Jurisdiction, Etc. Each party hereto hereby and any Person asserting rights as a third party beneficiary may do so only
if he, she or it irrevocably agrees that any Legal Proceeding shall be brought only to the exclusive jurisdiction of the Court
of Chancery of the State of Delaware or, if such court declines to exercise jurisdiction, the U.S. District Court for the District
of Delaware, and each party hereto hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts
therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by Law, any objection
that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any
such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period
a Legal Proceeding that is filed in accordance with this Section 7(j) is pending before a court, all actions, suits or proceedings
with respect to such Legal Proceeding or any other Legal Proceeding, including any counterclaim, cross-claim or interpleader, shall
be subject to the exclusive jurisdiction of such court. Each party hereto and any Person asserting rights as a third party beneficiary
may do so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Proceeding, that (a) such party is
not personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding may not
be brought or is not maintainable in such court, (c) such party’s property is exempt or immune from execution, (d) such action,
suit or proceeding is brought in an inconvenient forum, or (e) the venue of such action, suit or proceeding is improper. A final
judgment in any action, suit or proceeding described in this Section 7(j) following the expiration of any period permitted
for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by applicable Laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING RIGHTS AS A THIRD
PARTY BENEFICIARY MAY DO SO ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS
OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM
RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY
HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY COUNTERCLAIM
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON
ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER
LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

(k) Specific
Performance. The Company Stockholder agrees that irreparable damage would occur for which monetary damages, even if available,
would not be an adequate remedy in the event that the Company Stockholder does not perform its obligations under the provisions
of this Agreement in accordance with its specified terms or otherwise breach such provisions. The Company Stockholder acknowledges
and agrees that Parent shall therefore be entitled to an injunction or injunctions, specific performance or other equitable relief
to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any action instituted in any
court in the United States or in any state or province having jurisdiction over the parties hereto and the matter in addition to
any other remedy to which they may be entitled pursuant hereto, and that such explicit rights of specific enforcement are an integral
part of the transactions contemplated by this Agreement and without such rights, Parent would not have entered into this Agreement.
The Company Stockholder agrees that it will not oppose the granting of an injunction, specific performance and other equitable
relief on the basis that Parent have an adequate monetary or other remedy at law. The Company Stockholder acknowledges and agrees
that if Parent seeks an injunction or injunctions to prevent breaches of this Agreement or to enforce specifically the terms and
provisions of this Agreement, Parent shall not be required to provide any bond or other security in connection with any such order
or injunction.

 

(l) No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in Parent any direct or indirect ownership
or incidence of ownership of or with respect to the Equity Securities of the Company Stockholder. All rights, ownership and economic
benefits (but excluding, for the avoidance of doubt, any voting rights to the extent described herein) of and relating to the Equity
Securities of the Company Stockholder shall remain fully vested in and belong to the Company Stockholder, and Parent shall have
no authority to direct the Company Stockholder in the voting or disposition of any of the Stockholder’s Equity Securities,
except as otherwise provided herein.

 

(m) Capacity
as a Stockholder. Notwithstanding anything herein to the contrary, the Company Stockholder signs this Agreement solely in the
Company Stockholder’s capacity as a stockholder of the Company, and not in any other capacity (including as an officer or
director of the Company) and this Agreement shall not limit or otherwise affect the actions of the Company Stockholder (or any
affiliate, employee or designee of the Company Stockholder) in his or her capacity, if applicable, as an officer or director of
the Company or any other Person.

 

[Signature Pages Follow]

 

    9

     

    

 

IN WITNESS WHEREOF, Parent
and the Company Stockholder have caused this Transaction Support Agreement to be executed as of the date first written above.

 

	 	Parent:
	 	 
	 	Stable Road Acquisition Corp.
	 	 
	 	By:	 
	 	Name:  	Brian Kabot
	 	Title:	Chief Executive Officer

 

Signature Page to Support Agreement

 

    10

     

    

 

COMPANY STOCKHOLDER:

 

I have read this Support Agreement,
I have had the opportunity to consult legal counsel prior to my signing of this Support Agreement, I fully and completely understand
this Support Agreement and I hereby agree to and accept this Support Agreement.

 

_______________________________________

[NAME]

 

Signature Page to Support Agreement

 

    11

     

    

 

Schedule 1

 

Equity Securities

 

	Company
    Stockholder	 	Physical
    and Email Addresses for Notice	 	Class,
    Number and Type of Company Interests 
	[●]	 	[●]	 	[●]

 

 

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]